BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20414253)

  • 21. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    J Gastroenterol Hepatol; 1999 Jun; 14(6):594-9. PubMed ID: 10385071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal diagnosis of progressive familial intrahepatic cholestasis type 2.
    Chen ST; Chen HL; Su YN; Liu YJ; Ni YH; Hsu HY; Chu CS; Wang NY; Chang MH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1390-3. PubMed ID: 18853996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The MDR3 gene mutation: a rare cause of progressive familial intrahepatic cholestasis (PFIC)].
    Maisonnette F; Abita T; Barriere E; Pichon N; Vincensini JF; Descottes B
    Ann Chir; 2005 Oct; 130(9):581-3. PubMed ID: 16199000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.
    Strubbe B; Geerts A; Van Vlierberghe H; Colle I
    Acta Gastroenterol Belg; 2012 Dec; 75(4):405-10. PubMed ID: 23402083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11.
    van Mil SW; van der Woerd WL; van der Brugge G; Sturm E; Jansen PL; Bull LN; van den Berg IE; Berger R; Houwen RH; Klomp LW
    Gastroenterology; 2004 Aug; 127(2):379-84. PubMed ID: 15300568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive familial intrahepatic cholestasis.
    Srivastava A
    J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
    Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
    Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy.
    Schneider G; Paus TC; Kullak-Ublick GA; Meier PJ; Wienker TF; Lang T; van de Vondel P; Sauerbruch T; Reichel C
    Hepatology; 2007 Jan; 45(1):150-8. PubMed ID: 17187437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
    Dixon PH; Weerasekera N; Linton KJ; Donaldson O; Chambers J; Egginton E; Weaver J; Nelson-Piercy C; de Swiet M; Warnes G; Elias E; Higgins CF; Johnston DG; McCarthy MI; Williamson C
    Hum Mol Genet; 2000 May; 9(8):1209-17. PubMed ID: 10767346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and future therapies for inherited cholestatic liver diseases.
    van der Woerd WL; Houwen RH; van de Graaf SF
    World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial intrahepatic cholestasis: New and wide perspectives.
    Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
    Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis.
    Strautnieks SS; Bull LN; Knisely AS; Kocoshis SA; Dahl N; Arnell H; Sokal E; Dahan K; Childs S; Ling V; Tanner MS; Kagalwalla AF; Németh A; Pawlowska J; Baker A; Mieli-Vergani G; Freimer NB; Gardiner RM; Thompson RJ
    Nat Genet; 1998 Nov; 20(3):233-8. PubMed ID: 9806540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
    Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
    Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Phenotype and genetic analysis of a pedigree affected with progressive familial intrahepatic cholestasis].
    Wu Q; Ma B; Yang S; Mei S; Ma X; Kong X; Shi H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):789-793. PubMed ID: 31400129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.
    Imagawa K; Hayashi H; Sabu Y; Tanikawa K; Fujishiro J; Kajikawa D; Wada H; Kudo T; Kage M; Kusuhara H; Sumazaki R
    J Hum Genet; 2018 May; 63(5):569-577. PubMed ID: 29507376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis.
    Noe J; Kullak-Ublick GA; Jochum W; Stieger B; Kerb R; Haberl M; Müllhaupt B; Meier PJ; Pauli-Magnus C
    J Hepatol; 2005 Sep; 43(3):536-43. PubMed ID: 16039748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic differences in PFIC2 and BRIC2 correlate with protein stability of mutant Bsep and impaired taurocholate secretion in MDCK II cells.
    Kagawa T; Watanabe N; Mochizuki K; Numari A; Ikeno Y; Itoh J; Tanaka H; Arias IM; Mine T
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G58-67. PubMed ID: 17947449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.